Tvardi Therapeutics, Inc. (TVRD)
0.8571
-0.01
(-0.86%)
USD |
NASDAQ |
Nov 06, 10:30
Tvardi Therapeutics Max Drawdown (5Y) : 99.88% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 99.88% |
| September 30, 2026 | 99.84% |
| August 31, 2026 | 99.77% |
| July 31, 2026 | 99.77% |
| June 30, 2026 | 99.77% |
| May 31, 2026 | 99.73% |
| April 30, 2026 | 99.73% |
| March 31, 2026 | 99.70% |
| February 28, 2026 | 99.66% |
| January 31, 2026 | 99.64% |
| December 31, 2025 | 99.64% |
| November 30, 2025 | 99.64% |
| October 31, 2025 | 99.56% |
| September 30, 2025 | 99.17% |
| August 31, 2025 | 99.17% |
| July 31, 2025 | 99.17% |
| June 30, 2025 | 99.17% |
| May 31, 2025 | 99.17% |
| April 30, 2025 | 99.17% |
| March 31, 2025 | 99.17% |
| February 28, 2025 | 99.17% |
| January 31, 2025 | 99.17% |
| December 31, 2024 | 99.17% |
| November 30, 2024 | 99.17% |
| October 31, 2024 | 99.17% |
| Date | Value |
|---|---|
| September 30, 2024 | 99.17% |
| August 31, 2024 | 99.17% |
| July 31, 2024 | 99.17% |
| June 30, 2024 | 99.17% |
| May 31, 2024 | 98.22% |
| April 30, 2024 | 98.22% |
| March 31, 2024 | 98.22% |
| February 29, 2024 | 98.22% |
| January 31, 2024 | 98.18% |
| December 31, 2023 | 97.96% |
| November 30, 2023 | 96.81% |
| October 31, 2023 | 96.37% |
| September 30, 2023 | 94.28% |
| August 31, 2023 | 91.20% |
| July 31, 2023 | 91.13% |
| June 30, 2023 | 90.30% |
| May 31, 2023 | 89.11% |
| April 30, 2023 | 86.54% |
| March 31, 2023 | 83.25% |
| February 28, 2023 | 74.48% |
| January 31, 2023 | 74.48% |
| December 31, 2022 | 74.48% |
| November 30, 2022 | 74.48% |
| October 31, 2022 | 74.48% |
| September 30, 2022 | 74.48% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| ANI Pharmaceuticals, Inc. | 72.96% |
| Corcept Therapeutics, Inc. | 71.85% |
| Veru, Inc. | 99.12% |
| Johnson & Johnson | 18.44% |
| Eli Lilly & Co. | 34.47% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -80.35 |
| Beta (5Y) | 0.3657 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 94.98% |
| Historical Sharpe Ratio (5Y) | -0.8143 |
| Historical Sortino (5Y) | -1.214 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 48.05% |